HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
TELA
TELA Bio, Inc.
TELA lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
TELA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Unavailable |
TELA's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
TELA PE Valuation
TELA has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
TELA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TELA's losses to shrink, with revenue holding steady.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
TELA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.74 | +$0.09 |
| Q2 2026 | -$0.77 | +$0.29 |
| Q1 2026 | -$0.79 | +$0.56 |
| Q4 2025 | -$0.83 | +$0.50 |
| Q3 2025 | -$0.83 | +$0.83 |
| Q2 2025 | -$1.06 | +$0.63 |
| Q1 2025 | -$1.35 | +$0.29 |
| Q4 2024 | -$1.33 | +$0.71 |
TELA has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over TELA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over TELA on profitability, with a higher operating margin.
TELA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19M | -8.4% |
| Q2 2026 | $19.3M | -4.5% |
| Q1 2026 | $19.1M | +2.9% |
| Q4 2025 | $20.9M | +18% |
| Q3 2025 | $20.7M | +9.1% |
| Q2 2025 | $20.2M | +26% |
| Q1 2025 | $18.5M | +12% |
| Q4 2024 | $17.6M | +3.8% |
TELA's revenue has held roughly level: $19M last quarter, down 8.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -38% | -1.9 points |
| Q2 2026 | -48% | -3.2 points |
| Q1 2026 | -55% | +1.3 points |
| Q4 2025 | -32% | +16 points |
| Q3 2025 | -37% | +13 points |
| Q2 2025 | -45% | +27 points |
| Q1 2025 | -57% | -28 points |
| Q4 2024 | -47% | +25 points |
TELA's operating margin was −38% last quarter, down 1.9 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over TELA on cash generation, producing positive trailing cash flow while its opponent burns cash.
TELA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.7M | -$2.8M |
| Q2 2026 | -$9.4M | -$1.4M |
| Q1 2026 | -$11.3M | -$1.5M |
| Q4 2025 | -$5M | +$2.8M |
| Q3 2025 | -$5.9M | +$3.2M |
| Q2 2025 | -$8M | +$3M |
| Q1 2025 | -$9.8M | +$4.9M |
| Q4 2024 | -$7.8M | +$3.5M |
TELA has burned cash in almost every quarter: −$34M over the past year, against −$32M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over TELA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
TELA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +275K shares |
| 1 year | +27% | +12.3M shares |
| 3 years | +148% | +34.4M shares |
| 5 years | +299% | +43.2M shares |
| Available history | +406% | +46.3M shares |
TELA has 58M diluted shares, up 27% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
TELA Net Leverage
TELA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
TELA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.7 | Neutral |
| Stochastic | 25.3 | Neutral |
TELA's weekly RSI is 48 (neutral) and its Stochastic is 25 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
TELA PE vs Healthcare Sector
TELA has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
TELA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.99 | 13% below |
| 20 week MA | $0.88 | 2.3% below |
| 50 week MA | $0.88 | 2.3% below |
| 100 week MA | $1.34 | 36% below |
| 200 week MA | $4.07 | 79% below |
TELA is in a downtrend: it's below all five of its weekly moving averages, and 79% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
TELA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.7 | $16.0 | +26% |
| 2021 | $16.0 | $12.5 | -22% |
| 2022 | $12.5 | $11.3 | -10% |
| 2023 | $11.3 | $6.62 | -41% |
| 2024 | $6.62 | $2.91 | -56% |
| 2025 | $2.91 | $1.14 | -61% |
| 2026 YTD | $1.14 | $0.86 | -25% |
TELA has the edge over HIMS on returns for 2026, with the stronger performance.